SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-030435
Filing Date
2024-04-04
Accepted
2024-04-04 16:29:57
Documents
14
Period of Report
2024-04-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0203327-8k_bio.htm   iXBRL 8-K 32873
2 CONSENT OF BOARD OF DIRECTORS (AND EXHIBIT) ea020332701ex99-1_bio.htm EX-99.1 74791
  Complete submission text file 0001213900-24-030435.txt   291820

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bioe-20240404.xsd EX-101.SCH 3033
4 XBRL LABEL FILE bioe-20240404_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bioe-20240404_pre.xml EX-101.PRE 22371
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0203327-8k_bio_htm.xml XML 3381
Mailing Address 8 STUDEBAKER DRIVE IRVINE CA 92618
Business Address 8 STUDEBAKER DRIVE IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56263 | Film No.: 24823485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)